Leah Martell

440 total citations
7 papers, 307 citations indexed

About

Leah Martell is a scholar working on Immunology, Genetics and Epidemiology. According to data from OpenAlex, Leah Martell has authored 7 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Genetics and 2 papers in Epidemiology. Recurrent topics in Leah Martell's work include Complement system in diseases (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Iron Metabolism and Disorders (2 papers). Leah Martell is often cited by papers focused on Complement system in diseases (3 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Iron Metabolism and Disorders (2 papers). Leah Martell collaborates with scholars based in United States, United Kingdom and Germany. Leah Martell's co-authors include Karim Kentouche, Lawrence Rice, Reinhard Schneppenheim, Holly A. Field, Bruce M. Ewenstein, Johanna A. Kremer Hovinga, Allan M. Goldstein, Marie Scully, Michiko Kajiwara and Fabrizio C. Serluca and has published in prestigious journals such as Blood, Neurology and Vaccine.

In The Last Decade

Leah Martell

7 papers receiving 301 citations

Peers

Leah Martell

IMMUN

HEMAT

NEPHR

EPIDE

GENET

Sophie Gié France

Francisco Lendínez Spain

Katherine E. Lintner United States

E.S. Curtoni Italy

Toyomi Kamesaki Japan

Ortraud Beringer Germany

Doured Daghistani United States

İzzet Berkel Türkiye

Wilma Carvalho Neves Forte Brazil

Shagun Sharma India

Sophie Gié France

Leah Martell

314 ×1.9

IMMUN

121 ×1.1

HEMAT

247 ×3.2

NEPHR

28 ×0.4

EPIDE

45 ×0.7

GENET

Citations per year, relative to Leah Martell Leah Martell (= 1×) peers Sophie Gié

Countries citing papers authored by Leah Martell

Since Specialization

Citations

This map shows the geographic impact of Leah Martell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leah Martell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leah Martell more than expected).

Fields of papers citing papers by Leah Martell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leah Martell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leah Martell. The network helps show where Leah Martell may publish in the future.

Co-authorship network of co-authors of Leah Martell

This figure shows the co-authorship network connecting the top 25 collaborators of Leah Martell. A scholar is included among the top collaborators of Leah Martell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leah Martell. Leah Martell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Jain, Nisha, et al.. (2021). Recombinant ADAMTS13 for Patients with Severe Congenital Thrombotic Thrombocytopenic Purpura: Design of a Phase 3b Open-Label Continuation Study of Prophylactic and on-Demand Treatment. Blood. 138(Supplement 1). 4252–4252. 4 indexed citations

2.

Scully, Marie, Paul Knöbl, Karim Kentouche, et al.. (2017). Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura. Blood. 130(19). 2055–2063. 173 indexed citations

3.

Leroux‐Roels, Geert, Cathy Maes, Julie Willekens, et al.. (2016). A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women. Vaccine. 34(15). 1786–1791. 50 indexed citations

4.

Scully, Marie, Paul Knoebl, Karim Kentouche, et al.. (2016). Pharmacodynamic Profile of a Recombinant ADAMTS13 (BAX930) in Hereditary Thrombotic Thrombocytopenic Purpura (Upshaw-Schulman Syndrome (USS)). Blood. 128(22). 135–135. 9 indexed citations

5.

Vermersch, Patrick, Óscar Fernández, F. Baldinetti, et al.. (2015). Evaluation of Comprehensive Alemtuzumab Infusion Guidance in Patients With Relapsing-Remitting Multiple Sclerosis: EMERALD Study Design (P7.283). Neurology. 84(14_supplement). 1 indexed citations

6.

Brinar, Vesna, Gavin Giovannoni, Eva Havrdová, et al.. (2015). A Phase 3b/4 Long-Term Study of Alemtuzumab in Patients With Relapsing-Remitting Multiple Sclerosis: TOPAZ Study Design (P7.219). Neurology. 84(14_supplement). 3 indexed citations

7.

Field, Holly A., et al.. (2009). Analysis of gastrointestinal physiology using a novel intestinal transit assay in zebrafish. Neurogastroenterology & Motility. 21(3). 304–312. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact